EnGeneIC Publishes the COVID-EDV Vaccine's Novel Mechanism of Action in a Leading Immunology Journal
EnGeneIC Publishes the COVID-EDV Vaccine's Novel Mechanism of Action in a Leading Immunology Journal
Stay updated with breaking news from Kumar Visvanathan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EnGeneIC Publishes the COVID-EDV Vaccine's Novel Mechanism of Action in a Leading Immunology Journal
Gilead Sciences • Five diverse research projects spanning COVID-19, HIV, hepatitis C elimination, CAR T cell therapy and fungal infections are the 2021 recipients of the Gilead Fellowship Research Grant. • Now in its 11th year, the Fellowship has granted more than $2.6 million to research projects throughout Australia which often struggle to secure funding or face high competition. Melbourne, 29 June 2021 – Gilead Sciences Australia today announced the five recipients of the 2021 Gilead Fellowship Research Grants Program one of which will investigate the medium- and long-term impacts of...